Okan Çan represents market-leading companies in the protection and enforcement of IP rights. His expertise extends to IP litigation, IP strategy, transactional intellectual property, technology licensing, data privacy and publicity rights.

Mr. Çan has achieved notable results in IP disputes. He has represented:

• leading pharma firms in several IP litigations;

• a leading technology market player in an extensive project for licensing its standard-essential patents;
• a multinational firm in complex multi-jurisdictional IP litigation, achieving one of the highest compensation awards for an IP conflict in Turkey;
• a multinational tobacco firm during the acquisition of the IP assets of the Turkish state monopoly;
• a leading multinational firm for which he secured the first trademark registration for a colour per se in Turkey; and
• Leading entertainment content providers for their data privacy policies.

By invitation of the Turkish Patent and Trademark Office, in 2016 Mr. Çan participated in and actively worked with the commission established for the preparation of the new Turkish IP Code, which entered into force on 10 January 2017 before the code was enacted. He chaired a sub-committee of INTA’s Anti-Counterfeiting Committee between 2020-2022. Okan is currently serving as the first Turkish member of the Board of Directors of INTA and the member of the Executive Committee at INTA. Okan has also appointed as the first Turkish member to take place in founding the Global IP Alliance (GLIPA) in Atlanta. He is also serving as the Board Member at GLIPA.

Mr. Çan is listed in IAM Patent 1000, IP Stars, The Legal 500, Chamber and Partners, and WTR 1000 2016-2022 in the gold tier for litigation and enforcement. In 2022 he was awarded with best litigator biotech award throughout EMEA by Life Sciences Magazine.

Practice Areas & Work Department

Intellectual Property

Data Privacy

Languages

English

Memberships

INTA, Board Member

GLIPA